An in vivo study furthermore indicated that the administration of chemerin resulted in aggravation of DSS-induced colitis in mice by augmenting TNFα and IL-6 production, whereas a decrease in IL-10—producing anti-inflammatory macrophages could be detected. Here, RARRES2 is linked to colitis.